ReVision Implant
Develops a bionic vision implant designed to feed visual signals directly into the brain for sight restoration applications.
Overview
ReVision Implant is building a bionic eye, described as a vision device that feeds directly into the brain. The company targets medical applications for restoring or augmenting vision, with its core differentiation centered on a direct brain-interface approach rather than a conventional external vision aid. The company has raised $4M across one undisclosed round, announced on 2026-05-26 and described as a €4M financing. The funding positions ReVision Implant as an early-stage deep tech medical device company working at the intersection of neurotechnology and visual prosthetics.
Funding History
The bionic eye: ReVision Implant lands €4M for a vision device that feeds directly into your brain
Frequently Asked Questions
- How much has ReVision Implant raised in total?
- ReVision Implant has raised a total of $4M across 1 funding round.
- Who are ReVision Implant's investors?
- ReVision Implant's investors include Undisclosed.
- What does ReVision Implant do?
- ReVision Implant is building a bionic eye, described as a vision device that feeds directly into the brain. The company targets medical applications for restoring or augmenting vision, with its core differentiation centered on a direct brain-interface approach rather than a conventional external vision aid. The company has raised $4M across one undisclosed round, announced on 2026-05-26 and described as a €4M financing. The funding positions ReVision Implant as an early-stage deep tech medical device company working at the intersection of neurotechnology and visual prosthetics.
- Where is ReVision Implant headquartered?
- ReVision Implant is headquartered in San Francisco, CA.
Investors
Related Insights
A comprehensive analysis of Isembard's funding history, investors, competitive position, and growth trajectory in the Deep Tech space.
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
395 AI funding deals worth $337B tracked in 2026. Complete guide to raising pre-seed, seed, Series A/B/C+ for AI startups. Valuations, metrics VCs demand, top investors (Sequoia, a16z, Lightspeed), and how AI funding differs from traditional tech. Includes real deal sizes, timelines, and founder strategies.